Milunsky A, Canick JA: Maternal serum screening for neural tube and other defects. In Milunsky A (ed): Genetic Disorders and the Fetus. Diagnosis, Prevention, and Treatment, 5th ed. Baltimore, Johns Hopkins Universiry Press, 2004 Mujezinovic F, Alfirevic Z: Analgesia for amniocentesis or chorionic villus sampling. Cochrane Database Syst Rev 11:CD008580, 2011 New England Regional Genetics Group Perinatal Collaborative Study of Down Syndrome Screening: Combining maternal serum alpha-fetoprotein measurements and age to screen for Down syndrome in pregnant women under age 35. Am J Obstet Gynecol 160(3):575, 1989 Norton ME, Brar H, Weiss J, et al: Non-Invasive Chromosoml Evaluation (NICE) study: results of a multicenter prospective cohort study for detection offetal trisomy 21 and trisomy 18. Am J Obstet GynecoI207(2): 137.e1, 2012 Norton ME, Jacobsson B, Swamy GK, et al: Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 372(17): 1589,o2015 Norton ME, Jellife-Pawlowski LL, Currier R]: Chromosomal abnormalities detected by current prenatal screening and noninvasive prenatal testing. Obstet Gynecol 124(5):979,o2014 Nyberg DA, Souter L: Use of genetic sonography for adjusting the risk for fetal Down syndrome. Semin Perinatol 27(2): 130, 2003 Nyberg DA, Souter L, El-Bastawissi A, et al: Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy. J Ultrasound Med 20(10):1053, 2001 Odibo AO, Gray DL, Dicke JM, et al: Revisiting the fetal loss rate after secondtrimester genetic amniocentesis: a single center's 16-year experience. Obstet Gynecol 11o1(3):589,o2008 Orioli 1M, Catilla EE: Epidemiology ofholoprosencephaly: prevalence and risk factors. Am J Med Genet Part C Semin Med Genet 154C:13, 2010 Park F, Russo K, Williams P, et al: Prediction and prevention of early-onset pre-eclampsia: impact of aspirin after first-trimester screening. Ultrasound Obstet GynecoIo46(4):419, 2015 Pedersen RN, Calzolari E, Husby S, et al: Oesophageal atresia: prevalence, prenatal diagnosis, and associated anomalies in 23 European regions. Arch Dis Child 97(3):227,o2012 Pergament E, Cuckle H, Zimmermann B, et al: Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort. Obstet Gynecol 124(2 Pt 1):210, 2014 Perinatal Quality Foundation: NIPT/cell free DNA screening predictive value calculator. 2016. Available at: http://perinatalquality.org/. Accessed December 15, 2016 Persutte H, Lenke RR: Failure of amniotic-fluid-cell growth: is it related to fetal aneuploidy? Lancet 345(8942):96, 1995 Philip J, Silver RK, Wilson D, et al: Late first-trimester invasive prenatal diagnosis: results of an international randomized trial. Obstet Gynecol 103(6):1164,o2004 Quezada MS, Gil MM, Francisco C, et al: Screening for trisomies 21, 18, and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks. Ultrasound Obstet GynecoIo45(1):36, 2015